World Library  
Flag as Inappropriate
Email this Article

Quality Chemical Industries Limited

Article Id: WHEBN0024618079
Reproduction Date:

Title: Quality Chemical Industries Limited  
Author: World Heritage Encyclopedia
Language: English
Subject: Luzira, Index of Uganda-related articles
Publisher: World Heritage Encyclopedia

Quality Chemical Industries Limited

Quality Chemical Industries Limited
Type Private
Industry Pharmaceutical Industry
Founded 1998
Headquarters Luzira, Kampala, Uganda
Key people Francis X Kitaka
Emmanuel Katongole
Managing Director
Services Pharmaceutical manufacturing
Total assets US$120 million (2012)[1]
Employees 350 (2012)

Quality Chemical Industries Limited (QCIL), is a pharmaceutical manufacturing company in Uganda. It is the only company in Sub-Saharan Africa that manufactures triple-combination antiretroviral (ARV) drugs.[2]


The headquarters of the company are located on Katwe Road, in the neighborhood known as Katwe, in Makindye Division, in the southern part of Kampala, Uganda's capital and largest city.

The pharmaceutical manufacturing plant is located in the southeastern suburb of Kampala, known as Luzira, in Nakawa Division, approximately 11.5 kilometres (7.1 mi), by road, southeast of the central business district.[3]

The factory sits on 12 acres (4.9 ha), of well-mainicured lawns. The first plant was commissioned in 2007, with a capacity of 6 million tablets (pills) per day. A second plant is being planned on the premises, which will raise the manufacturing capacity to 18 million tablets (pills) daily.[4]

The coordinates of the QCIL pharmaceutical plant are:0° 18' 18.00"N, 32° 38' 24.00"E (Latitude:0.3050N; 32.6400E).


The company was formed in 1998 by six investors:

  • Randall Tierney
  • Edward Martin
  • Francis X. Kitaka - Chairman QCIL
  • Emmanuel Katongole - CEO QCIL
  • Fred Kitaka Mutebi - CFO QCIL
  • George Baguma - Director of Marketing QCIL

Initially QCIL focused on the importation of generic drugs from India. In 2004, QCIL convinced the Indian drug maker, Cipla, to go into a joint venture with QCIL and set up a pharmaceutical plant in Uganda. Ground was broken in 2005 and the factory was commissioned in 2007. [5]

New Manufacturing Plant

In 2007, the company commissioned a new pharmaceutical manufacturing plant in Luzira, a suburb of Kampala, Uganda's capital and largest city. The factory is a joint venture between QCIL, the Government of Uganda and the Indian pharmaceutical company Cipla. In 2009, TLG Capital invested an undisclosed amount of money in the project.[6] Subsequently Capitalworks Investment Partners, a private equity firm based in South Africa also became a shareholder in the pharmaceutical plant.

Besides manufacturing the triple-combination ARVs, the new factory will manufacture the new antimalarial drug Lumartem, containing artemisinin and lumefantrin. Lumartem has less drug resistance than some of the commoner antimalarials like Chloroquine. The new plant is estimated to cost about US$38 million.[7] In February 2010, the Government of Uganda divested from the new pharmaceutical plant by selling its shares, "at cost" to Quality Chemical Industries Limited. The transaction was valued at approximately US$5 million.[8]

In February 2011, the owners of the pharmaceutical factory announced an US$80 million expansion to the production line, to include increased production of antiretroviral and antimalarial medication.[9] In April 2012, British media reported that QCIL was in the process of expanding its manufacturing capacity fourfold. The factory has received a stamp of approval of its processes and products from the World Health Organization. The products will be initially marketed to the Eastern African countries of Burundi, Democratic Republic of the Congo, Kenya, Rwanda, Southern Sudan, Tanzania and Uganda.[10]

Ownership of Pharmaceutical Plant

As of February 2011, the shareholding in the pharmaceutical plant is as depicted in the table below:[11]

Shareholding In QCIL Pharmaceutical Plant
Rank Name of Owner Percentage Ownership
1 Cipla of India 41.80
2 QCIL of Uganda 41.80
3 Capitalworks Investment Partners of South Africa 08.20
4 TLG Capital of the United Kingdom 08.20
Total 100.00


The Chairman of the Board of Directors of QCIL is Francis X. Kitaka, the first person in East Africa to train as a biochemist.[12] The Managing Director of QCIL is Emmanuel Katongole.[13]

External references

  • Company Overview At
  • New QCIL Factory Commissioned in October 2007
  • About Cooper Uganda Limited, Sister Company to QCIL
  • TLG Capital
  • TLG Capital is Invested in QCIL

See also


Coordinates: 00°18′18″N 32°38′24″E / 0.30500°N 32.64000°E / 0.30500; 32.64000

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.